VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 38 filers reported holding VERONA PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $102,000 | -15.7% | 18,560 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $121,000 | -22.4% | 18,560 | -0.7% | 0.01% | -27.3% |
| Q1 2021 | $156,000 | +20.0% | 18,690 | +0.7% | 0.01% | 0.0% |
| Q4 2020 | $130,000 | -4.4% | 18,560 | -14.7% | 0.01% | -21.4% |
| Q3 2020 | $136,000 | +33.3% | 21,760 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $102,000 | +13.3% | 21,760 | 0.0% | 0.01% | +7.7% |
| Q1 2020 | $90,000 | -23.7% | 21,760 | +6.4% | 0.01% | -7.1% |
| Q4 2019 | $118,000 | +25.5% | 20,460 | 0.0% | 0.01% | +7.7% |
| Q3 2019 | $94,000 | +6.8% | 20,460 | +18.1% | 0.01% | 0.0% |
| Q2 2019 | $88,000 | -22.1% | 17,330 | 0.0% | 0.01% | -31.6% |
| Q1 2019 | $113,000 | – | 17,330 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,111,112 | $11,356,000 | 29.98% |
| Aisling Capital Management LP | 1,332,485 | $13,618,000 | 9.04% |
| Abingworth LLP | 2,457,500 | $25,091,000 | 8.58% |
| Fairmount Funds Management LLC | 2,678,982 | $27,379,000 | 4.81% |
| Vivo Capital, LLC | 4,249,918 | $43,434,000 | 4.80% |
| NEA Management Company, LLC | 5,584,753 | $57,076,000 | 2.85% |
| Octagon Capital Advisors LP | 1,324,868 | $13,540,000 | 2.34% |
| Samsara BioCapital, LLC | 938,890 | $9,595,000 | 2.24% |
| ACT CAPITAL MANAGEMENT, LLC | 143,500 | $1,467,000 | 2.02% |
| Frazier Life Sciences Management, L.P. | 2,099,541 | $21,457,000 | 1.65% |